PITAVASTATIN

PITAVASTATIN was reported 10341 times

These side effects are most commonly reported by patients taking PITAVASTATIN:

# Side effect Count
0 MYALGIA 459
1 DIARRHOEA 359
2 DIZZINESS 311
3 NAUSEA 306
4 DYSPNOEA 305
5 DECREASED APPETITE 301
6 HEADACHE 301
7 FATIGUE 300
8 MALAISE 292
9 PRURITUS 290
10 PYREXIA 290
11 FALL 282
12 ARTHRALGIA 280
13 ALTERED STATE OF CONSCIOUSNESS 262
14 ASTHENIA 261
15 INSOMNIA 254
16 HAEMORRHAGIC STROKE 250
17 TACHYCARDIA 250
18 COUGH 248
19 SEPSIS 248
20 VOMITING 246
21 CARDIO-RESPIRATORY ARREST 245
22 CHILLS 245
23 BLOOD PRESSURE INCREASED 242
24 HAEMATEMESIS 237
25 EYE PAIN 235
26 ABDOMINAL PAIN 233
27 BLINDNESS 231
28 OCULAR DISCOMFORT 231
29 ASCITES 230
30 HEAD DISCOMFORT 230
31 AMAUROSIS FUGAX 228
32 COMA 227
33 HAEMATURIA 223
34 SOMNOLENCE 223
35 SYNCOPE 221
36 TINNITUS 218
37 ABDOMINAL PAIN UPPER 212
38 GENERALISED OEDEMA 208
39 DIPLOPIA 200
40 PRESYNCOPE 198
41 URINARY TRACT DISORDER 198
42 VISION BLURRED 188
43 DRUG INTERACTION 174
44 PHOTOPHOBIA 168
45 OFF LABEL USE 153
46 DRUG INEFFECTIVE 95
47 HEPATIC FUNCTION ABNORMAL 91
48 ANAEMIA 90
49 PNEUMONIA 90
50 INTERSTITIAL LUNG DISEASE 82
51 RENAL IMPAIRMENT 80
52 MUSCLE SPASMS 74
53 PAIN 73
54 GAIT DISTURBANCE 71
55 RASH 62
56 ACUTE KIDNEY INJURY 61
57 CARDIAC FAILURE 61
58 ALANINE AMINOTRANSFERASE INCREASED 60
59 ASPARTATE AMINOTRANSFERASE INCREASED 60
60 DRUG INTOLERANCE 60
61 CONDITION AGGRAVATED 55
62 DEHYDRATION 55
63 RHABDOMYOLYSIS 54
64 HYPERTENSION 53
65 BACK PAIN 52
66 BLOOD CREATINE PHOSPHOKINASE INCREASED 52
67 CEREBRAL INFARCTION 51
68 HYPOTENSION 47
69 OEDEMA PERIPHERAL 46
70 PLATELET COUNT DECREASED 45
71 WEIGHT DECREASED 43
72 LIVER DISORDER 40
73 CONSTIPATION 39
74 C-REACTIVE PROTEIN INCREASED 38
75 FEBRILE NEUTROPENIA 38
76 MUSCULAR WEAKNESS 38
77 NEUTROPENIA 38
78 URINARY TRACT INFECTION 38
79 MYOCARDIAL INFARCTION 37
80 PALPITATIONS 36
81 CHEST PAIN 35
82 BLOOD GLUCOSE INCREASED 34
83 CHRONIC KIDNEY DISEASE 34
84 DRUG-INDUCED LIVER INJURY 34
85 WEIGHT INCREASED 34
86 ANXIETY 33
87 ATRIAL FIBRILLATION 33
88 MALIGNANT NEOPLASM PROGRESSION 32
89 NEUROPATHY PERIPHERAL 32
90 PAIN IN EXTREMITY 32
91 PNEUMONIA ASPIRATION 32
92 PRODUCT USE IN UNAPPROVED INDICATION 32
93 RENAL FAILURE 32
94 WHITE BLOOD CELL COUNT DECREASED 32
95 BLOOD CREATININE INCREASED 31
96 DEATH 31
97 LOSS OF CONSCIOUSNESS 31
98 NEUTROPHIL COUNT DECREASED 30
99 HYPOAESTHESIA 29
100 METABOLIC ACIDOSIS 29
101 PEMPHIGOID 29
102 DEPRESSION 28
103 MYOPATHY 28
104 PLEURAL EFFUSION 28
105 TOXICITY TO VARIOUS AGENTS 28
106 HYPOGLYCAEMIA 27
107 BLOOD PRESSURE DECREASED 26
108 COVID-19 26
109 GLYCOSYLATED HAEMOGLOBIN INCREASED 26
110 HYPERKALAEMIA 26
111 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 26
112 ACUTE MYOCARDIAL INFARCTION 25
113 BRADYCARDIA 25
114 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25
115 HYPOTHYROIDISM 25
116 PARAESTHESIA 25
117 ASTHMA 24
118 BLOOD CHOLESTEROL INCREASED 24
119 DRUG ERUPTION 24
120 DYSPNOEA EXERTIONAL 24
121 HEPATIC ENZYME INCREASED 24
122 HYPOKALAEMIA 24
123 SEIZURE 24
124 URTICARIA 24
125 ERYTHEMA 23
126 HYPERCHOLESTEROLAEMIA 23
127 IMMUNE-MEDIATED MYOSITIS 23
128 TOXIC ENCEPHALOPATHY 23
129 WHITE BLOOD CELL COUNT INCREASED 23
130 ABDOMINAL DISCOMFORT 22
131 OEDEMA 22
132 OVERDOSE 22
133 PNEUMONIA BACTERIAL 22
134 THROMBOCYTOPENIA 22
135 TRANSAMINASES INCREASED 22
136 ANGINA PECTORIS 21
137 ARRHYTHMIA 21
138 BLOOD LACTATE DEHYDROGENASE INCREASED 21
139 CHEST DISCOMFORT 21
140 INFECTION 21
141 PRODUCT USE ISSUE 21
142 PRODUCTIVE COUGH 21
143 PROSTATE CANCER 21
144 CARDIAC FAILURE ACUTE 20
145 DRUG HYPERSENSITIVITY 20
146 GASTROINTESTINAL HAEMORRHAGE 20
147 HYPERGLYCAEMIA 20
148 PANCYTOPENIA 20
149 RESPIRATORY TRACT INFECTION 20
150 CONTUSION 19
151 DIABETES MELLITUS 19
152 DIABETIC KETOACIDOSIS 19
153 GASTROOESOPHAGEAL REFLUX DISEASE 19
154 HEART RATE INCREASED 19
155 HYPERHIDROSIS 19
156 HYPERSENSITIVITY 19
157 MYOSITIS 19
158 RENAL DISORDER 19
159 SEPTIC SHOCK 19
160 TREMOR 18
161 DEPRESSED LEVEL OF CONSCIOUSNESS 17
162 DRUG LEVEL INCREASED 17
163 DYSARTHRIA 17
164 DYSLIPIDAEMIA 17
165 GENERAL PHYSICAL HEALTH DETERIORATION 17
166 HYPOCALCAEMIA 17
167 LACTIC ACIDOSIS 17
168 SINUSITIS 17
169 SUBDURAL HAEMATOMA 17
170 TREATMENT NONCOMPLIANCE 17
171 ABDOMINAL DISTENSION 16
172 CARDIAC FAILURE CONGESTIVE 16
173 CYTOKINE RELEASE SYNDROME 16
174 EMOTIONAL DISTRESS 16
175 HERPES ZOSTER 16
176 INFLUENZA 16
177 INFUSION RELATED REACTION 16
178 PERIPHERAL SWELLING 16
179 RESPIRATORY FAILURE 16
180 RHINORRHOEA 16
181 SHOCK 16
182 BLOOD TRIGLYCERIDES INCREASED 15
183 DYSURIA 15
184 FEELING ABNORMAL 15
185 HAEMORRHAGE 15
186 INJECTION SITE PAIN 15
187 JAUNDICE 15
188 NASOPHARYNGITIS 15
189 PULMONARY EMBOLISM 15
190 SLEEP DISORDER 15
191 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15
192 ANGIOEDEMA 14
193 ANURIA 14
194 BLOOD UREA INCREASED 14
195 CELLULITIS 14
196 COGNITIVE DISORDER 14
197 CONTRAINDICATED PRODUCT ADMINISTERED 14
198 CORONARY ARTERY DISEASE 14
199 DEEP VEIN THROMBOSIS 14
200 GASTROINTESTINAL DISORDER 14
201 HAEMOGLOBIN DECREASED 14
202 HEPATOTOXICITY 14
203 HYPONATRAEMIA 14
204 MOBILITY DECREASED 14
205 MOVEMENT DISORDER 14
206 SUICIDE ATTEMPT 14
207 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14
208 UPPER GASTROINTESTINAL HAEMORRHAGE 14
209 BLOOD ALKALINE PHOSPHATASE INCREASED 13
210 CEREBRAL HAEMORRHAGE 13
211 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13
212 DIABETES MELLITUS INADEQUATE CONTROL 13
213 DISSEMINATED INTRAVASCULAR COAGULATION 13
214 ENCEPHALOPATHY 13
215 ENTEROCOLITIS 13
216 INFLUENZA LIKE ILLNESS 13
217 INTENTIONAL OVERDOSE 13
218 TRANSIENT ISCHAEMIC ATTACK 13
219 ACCIDENTAL EXPOSURE TO PRODUCT 12
220 ARTERIOSCLEROSIS 12
221 DELIRIUM 12
222 ELECTROCARDIOGRAM QT PROLONGED 12
223 FEMORAL NECK FRACTURE 12
224 INFLAMMATION 12
225 MELAENA 12
226 MEMORY IMPAIRMENT 12
227 OSTEOPOROSIS 12
228 OXYGEN SATURATION DECREASED 12
229 PYELONEPHRITIS 12
230 RHEUMATOID ARTHRITIS 12
231 SKIN LESION 12
232 TUBULOINTERSTITIAL NEPHRITIS 12
233 ALOPECIA 11
234 BALANCE DISORDER 11
235 CARDIAC ARREST 11
236 COLON CANCER 11
237 DERMATITIS ALLERGIC 11
238 EOSINOPHILIA 11
239 ERYTHEMA MULTIFORME 11
240 FACE OEDEMA 11
241 FLATULENCE 11
242 GLOMERULAR FILTRATION RATE DECREASED 11
243 HALLUCINATION 11
244 HEPATIC STEATOSIS 11
245 HYPERTENSIVE CRISIS 11
246 HYPERURICAEMIA 11
247 LUNG DISORDER 11
248 PRODUCT DOSE OMISSION ISSUE 11
249 PULMONARY SEPSIS 11
250 CARDIAC FAILURE CHRONIC 10
251 CATARACT 10
252 COLITIS 10
253 DRY SKIN 10
254 DYSPNOEA AT REST 10
255 FLUID RETENTION 10
256 HYPOPHAGIA 10
257 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10
258 LYMPHOCYTE COUNT DECREASED 10
259 ODYNOPHAGIA 10
260 PANCREATITIS ACUTE 10
261 PULMONARY TOXICITY 10
262 STRESS CARDIOMYOPATHY 10
263 VENTRICULAR EXTRASYSTOLES 10
264 VIRAL INFECTION 10
265 AKINESIA 9
266 ATRIOVENTRICULAR BLOCK COMPLETE 9
267 BASAL CELL CARCINOMA 9
268 BILE DUCT STONE 9
269 CEREBROVASCULAR ACCIDENT 9
270 CHOLELITHIASIS 9
271 COLITIS MICROSCOPIC 9
272 COMPRESSION FRACTURE 9
273 CONJUNCTIVITIS 9
274 CORONARY ARTERY STENOSIS 9
275 DRY MOUTH 9
276 DYSPHONIA 9
277 EPILEPSY 9
278 ERECTILE DYSFUNCTION 9
279 EYE IRRITATION 9
280 EYELID OEDEMA 9
281 HYPERCALCAEMIA 9
282 INADEQUATE ANALGESIA 9
283 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9
284 INCORRECT DOSE ADMINISTERED 9
285 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9
286 MUSCLE RIGIDITY 9
287 ORAL CANDIDIASIS 9
288 OROPHARYNGEAL DISCOMFORT 9
289 PANCREATIC CARCINOMA 9
290 POLLAKIURIA 9
291 QUALITY OF LIFE DECREASED 9
292 RASH PRURITIC 9
293 RHINITIS ALLERGIC 9
294 SKIN ULCER 9
295 SPINAL COMPRESSION FRACTURE 9
296 SQUAMOUS CELL CARCINOMA 9
297 STEVENS-JOHNSON SYNDROME 9
298 STOMATITIS 9
299 TACHYPNOEA 9
300 TENDONITIS 9
301 ACUTE CORONARY SYNDROME 8
302 ANAPHYLACTIC SHOCK 8
303 ANHEDONIA 8
304 BACTERAEMIA 8
305 BLISTER 8
306 BLOOD BILIRUBIN INCREASED 8
307 BLOOD PRESSURE ABNORMAL 8
308 BRONCHITIS CHRONIC 8
309 CHOLECYSTITIS 8
310 CONCOMITANT DISEASE AGGRAVATED 8
311 COVID-19 PNEUMONIA 8
312 DEPRESSED MOOD 8
313 DISEASE PROGRESSION 8
314 DYSGEUSIA 8
315 DYSPHAGIA 8
316 EXTRAPYRAMIDAL DISORDER 8
317 FAECES DISCOLOURED 8
318 GAIT INABILITY 8
319 HAEMARTHROSIS 8
320 HAEMATOCHEZIA 8
321 HYDRONEPHROSIS 8
322 HYPOMAGNESAEMIA 8
323 IMMUNE-MEDIATED ENTEROCOLITIS 8
324 INJECTION SITE ERYTHEMA 8
325 LIMB INJURY 8
326 LOW DENSITY LIPOPROTEIN INCREASED 8
327 MIGRAINE 8
328 MYELOSUPPRESSION 8
329 NEURALGIA 8
330 OSTEOARTHRITIS 8
331 POOR QUALITY SLEEP 8
332 RASH PAPULAR 8
333 SPINAL STENOSIS 8
334 SUICIDAL IDEATION 8
335 UNDERDOSE 8
336 VULVOVAGINAL INFLAMMATION 8
337 ACUTE RESPIRATORY FAILURE 7
338 ADRENAL INSUFFICIENCY 7
339 ANGINA UNSTABLE 7
340 AUTOIMMUNE HEPATITIS 7
341 BLOOD POTASSIUM DECREASED 7
342 BONE MARROW FAILURE 7
343 BONE PAIN 7
344 BRAIN NATRIURETIC PEPTIDE INCREASED 7
345 BRONCHITIS 7
346 CARDIAC DISCOMFORT 7
347 CHOKING 7
348 CONFUSIONAL STATE 7
349 CREATINE KINASE INCREASED 7
350 CYTOMEGALOVIRUS INFECTION 7
351 DYSPEPSIA 7
352 EMBOLIC CEREBRAL INFARCTION 7
353 EPISTAXIS 7
354 EUGLYCAEMIC DIABETIC KETOACIDOSIS 7
355 FEMUR FRACTURE 7
356 FRACTURE 7
357 HAEMOPTYSIS 7
358 HEPATIC PAIN 7
359 HEPATITIS ACUTE 7
360 INTERNAL HAEMORRHAGE 7
361 INTESTINAL OBSTRUCTION 7
362 JOINT DISLOCATION 7
363 LEUKOPENIA 7
364 LIP OEDEMA 7
365 LIVER FUNCTION TEST ABNORMAL 7
366 LUNG INFILTRATION 7
367 MUSCULOSKELETAL STIFFNESS 7
368 MYOCARDIAL ISCHAEMIA 7
369 OROPHARYNGEAL PAIN 7
370 OSTEOMYELITIS 7
371 PANIC DISORDER 7
372 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 7
373 PHYSICAL DECONDITIONING 7
374 ROAD TRAFFIC ACCIDENT 7
375 SHOCK HAEMORRHAGIC 7
376 SINUS NODE DYSFUNCTION 7
377 SKIN DISORDER 7
378 SKIN EXFOLIATION 7
379 SPINAL OSTEOARTHRITIS 7
380 TAKAYASU^S ARTERITIS 7
381 THERAPY CESSATION 7
382 THERAPY NON-RESPONDER 7
383 URINARY INCONTINENCE 7
384 VERTIGO 7
385 ACUTE RESPIRATORY DISTRESS SYNDROME 6
386 ADRENAL ADENOMA 6
387 AFFECTIVE DISORDER 6
388 AMYLOID RELATED IMAGING ABNORMALITY-OEDEMA/EFFUSION 6
389 ANORGASMIA 6
390 BENIGN PROSTATIC HYPERPLASIA 6
391 CARDIAC DISORDER 6
392 CHOLANGITIS 6
393 CHOLECYSTITIS ACUTE 6
394 CHROMATURIA 6
395 DEMENTIA 6
396 DIVERTICULITIS 6
397 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6
398 DYSKINESIA 6
399 ECZEMA 6
400 EMBOLIC STROKE 6
401 EYE PRURITUS 6
402 FEAR 6
403 FEAR OF DISEASE 6
404 GASTRIC CANCER 6
405 GASTRIC ULCER 6
406 GASTROENTERITIS 6
407 GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 6
408 HAEMORRHAGE SUBCUTANEOUS 6
409 HEART RATE DECREASED 6
410 HEPATIC FAILURE 6
411 HOSPITALISATION 6
412 HYPERAESTHESIA 6
413 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 6
414 HYPERSOMNIA 6
415 HYPERTRIGLYCERIDAEMIA 6
416 HYPOPITUITARISM 6
417 HYPOTHERMIA 6
418 ILL-DEFINED DISORDER 6
419 INTENTIONAL DOSE OMISSION 6
420 LETHARGY 6
421 LIVER FUNCTION TEST INCREASED 6
422 MERYCISM 6
423 MUCOSAL INFLAMMATION 6
424 NASAL CONGESTION 6
425 NECK PAIN 6
426 NO ADVERSE EVENT 6
427 OSTEONECROSIS OF JAW 6
428 PAIN OF SKIN 6
429 PERITONITIS 6
430 PNEUMOTHORAX 6
431 PRESCRIBED UNDERDOSE 6
432 PRODUCT ADMINISTRATION ERROR 6
433 PROTEIN URINE PRESENT 6
434 PROTEINURIA 6
435 PULMONARY HYPERTENSION 6
436 PYELONEPHRITIS ACUTE 6
437 RASH MACULO-PAPULAR 6
438 RIB FRACTURE 6
439 SACRAL PAIN 6
440 SUBARACHNOID HAEMORRHAGE 6
441 TENDON RUPTURE 6
442 THERAPEUTIC RESPONSE DECREASED 6
443 THERAPY INTERRUPTED 6
444 THROMBOSIS 6
445 TOXIC EPIDERMAL NECROLYSIS 6
446 TREATMENT FAILURE 6
447 TYPE 2 DIABETES MELLITUS 6
448 URINARY RETENTION 6
449 VENTRICULAR TACHYCARDIA 6
450 VISCERAL PAIN 6
451 ADRENAL DISORDER 5
452 AGGRESSION 5
453 AMNESIA 5
454 AMYLASE INCREASED 5
455 APHASIA 5
456 BLOOD ALBUMIN DECREASED 5
457 BLOOD POTASSIUM INCREASED 5
458 BLOOD PRESSURE FLUCTUATION 5
459 BLOOD PRESSURE SYSTOLIC DECREASED 5
460 BURNING SENSATION 5
461 CARDIAC TAMPONADE 5
462 COLD SWEAT 5
463 CORONARY ARTERY OCCLUSION 5
464 DEVICE MALFUNCTION 5
465 DEVICE RELATED INFECTION 5
466 DIABETIC NEPHROPATHY 5
467 DRY EYE 5
468 DUODENAL ULCER 5
469 DUODENAL ULCER HAEMORRHAGE 5
470 DYSBIOSIS 5
471 END STAGE RENAL DISEASE 5
472 ENTERITIS 5
473 EYELID PTOSIS 5
474 FLUSHING 5
475 GASTROINTESTINAL PERFORATION 5
476 HAEMOGLOBIN INCREASED 5
477 HEMIPLEGIA 5
478 HEPATITIS 5
479 HIGH DENSITY LIPOPROTEIN DECREASED 5
480 HOT FLUSH 5
481 HYPERLIPIDAEMIA 5
482 HYPERTHYROIDISM 5
483 ILEUS 5
484 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 5
485 IMMUNE-MEDIATED HEPATIC DISORDER 5
486 INJECTION SITE SWELLING 5
487 INTENTIONAL PRODUCT MISUSE 5
488 INTERNATIONAL NORMALISED RATIO INCREASED 5
489 IRRITABILITY 5
490 LARGE INTESTINE POLYP 5
491 LIPIDS ABNORMAL 5
492 LUNG NEOPLASM MALIGNANT 5
493 LUPUS-LIKE SYNDROME 5
494 LYMPHADENOPATHY 5
495 LYMPHOCYTE STIMULATION TEST POSITIVE 5
496 LYMPHOMA 5
497 MEDICATION ERROR 5
498 MITRAL VALVE INCOMPETENCE 5
499 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 5
500 NEOPLASM PROGRESSION 5
501 ORTHOSTATIC HYPOTENSION 5
502 OSTEOPENIA 5
503 PAPULE 5
504 PERIPHERAL ARTERY OCCLUSION 5
505 PNEUMOCYSTIS JIROVECII PNEUMONIA 5
506 PRESCRIBED OVERDOSE 5
507 PROTHROMBIN TIME RATIO INCREASED 5
508 PULMONARY OEDEMA 5
509 RADIATION PNEUMONITIS 5
510 RECTAL HAEMORRHAGE 5
511 RESPIRATORY DISORDER 5
512 SECONDARY ADRENOCORTICAL INSUFFICIENCY 5
513 SEROTONIN SYNDROME 5
514 SKIN EROSION 5
515 SMALL INTESTINAL PERFORATION 5
516 SUDDEN DEATH 5
517 SURGERY 5
518 TENSION HEADACHE 5
519 THYROIDITIS 5
520 ABDOMINAL PAIN LOWER 4
521 ABNORMAL BEHAVIOUR 4
522 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4
523 ADVERSE EVENT 4
524 ANTIPHOSPHOLIPID SYNDROME 4
525 APPENDICITIS 4
526 ARTHRITIS 4
527 AUTOIMMUNE THYROIDITIS 4
528 BACTERIAL INFECTION 4
529 BLOOD CALCIUM DECREASED 4
530 BLOOD CHLORIDE DECREASED 4
531 BLOOD IRON DECREASED 4
532 BLOOD LACTIC ACID INCREASED 4
533 BLOOD PRESSURE SYSTOLIC INCREASED 4
534 BONE DENSITY DECREASED 4
535 BRAIN HERNIATION 4
536 BREAST CANCER 4
537 CARDIAC DYSFUNCTION 4
538 CARDIOGENIC SHOCK 4
539 CHOLESTASIS 4
540 CHRONIC GASTRITIS 4
541 COAGULATION TIME PROLONGED 4
542 COLITIS ISCHAEMIC 4
543 COMPLETED SUICIDE 4
544 CONDUCTION DISORDER 4
545 CONTRAINDICATED PRODUCT PRESCRIBED 4
546 CYSTITIS 4
547 CYTOMEGALOVIRUS TEST POSITIVE 4
548 DEAFNESS 4
549 DERMATITIS ACNEIFORM 4
550 DERMATITIS ATOPIC 4
551 DIFFUSE LARGE B-CELL LYMPHOMA 4
552 DIPLEGIA 4
553 DIVERTICULAR PERFORATION 4
554 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4
555 DRUG WITHDRAWAL SYNDROME 4
556 ECONOMIC PROBLEM 4
557 EJECTION FRACTION DECREASED 4
558 EMPHYSEMA 4
559 ENCEPHALITIS 4
560 ENDOCARDITIS 4
561 EXTRADURAL HAEMATOMA 4
562 FAECES SOFT 4
563 FAILURE TO SUSPEND MEDICATION 4
564 FANCONI SYNDROME 4
565 GAMMA-GLUTAMYLTRANSFERASE 4
566 GASTRIC POLYPS 4
567 GASTROINTESTINAL ULCER 4
568 GINGIVAL SWELLING 4
569 GLOMERULONEPHRITIS 4
570 GYNAECOMASTIA 4
571 HAEMATOCRIT DECREASED 4
572 HAEMORRHAGIC CEREBRAL INFARCTION 4
573 HEAT ILLNESS 4
574 HEPATIC ENZYME ABNORMAL 4
575 HEPATITIS CHOLESTATIC 4
576 HICCUPS 4
577 HYPERNATRAEMIA 4
578 HYPERTRANSAMINASAEMIA 4
579 ILLNESS 4
580 IMMUNE-MEDIATED MYOCARDITIS 4
581 INFECTIVE SPONDYLITIS 4
582 INJECTION SITE REACTION 4
583 INTENTIONAL PRODUCT USE ISSUE 4
584 IRRITABLE BOWEL SYNDROME 4
585 ISCHAEMIC STROKE 4
586 LACUNAR INFARCTION 4
587 LARGE INTESTINE PERFORATION 4
588 LIP EROSION 4
589 LOW DENSITY LIPOPROTEIN ABNORMAL 4
590 LOWER LIMB FRACTURE 4
591 LUNG INFECTION 4
592 LYMPHOPENIA 4
593 MALNUTRITION 4
594 MOUTH ULCERATION 4
595 MUSCULOSKELETAL PAIN 4
596 NECROTISING MYOSITIS 4
597 NEPHROGENIC ANAEMIA 4
598 NEPHROLITHIASIS 4
599 NEPHROPATHY TOXIC 4
600 NEUTROPHIL COUNT INCREASED 4
601 NIGHTMARE 4
602 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 4
603 OCULAR HYPERAEMIA 4
604 OESOPHAGEAL CANDIDIASIS 4
605 OESOPHAGITIS 4
606 ORGANISING PNEUMONIA 4
607 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4
608 PERIPHERAL ISCHAEMIA 4
609 PHARYNGITIS 4
610 POLYMYALGIA RHEUMATICA 4
611 POLYMYOSITIS 4
612 PRODUCT COMMUNICATION ISSUE 4
613 PRODUCT STORAGE ERROR 4
614 PRODUCT SUBSTITUTION ISSUE 4
615 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4
616 PULMONARY ALVEOLAR HAEMORRHAGE 4
617 PULMONARY CONGESTION 4
618 RENAL CYST 4
619 RENAL FAILURE ACUTE 4
620 RESPIRATORY DISTRESS 4
621 RETINAL HAEMORRHAGE 4
622 RIGHT VENTRICULAR FAILURE 4
623 SLEEP APNOEA SYNDROME 4
624 SMALL INTESTINAL HAEMORRHAGE 4
625 SUPRAVENTRICULAR TACHYCARDIA 4
626 SWOLLEN TONGUE 4
627 SYMPTOM RECURRENCE 4
628 TOXIC SKIN ERUPTION 4
629 TRANSPLANT REJECTION 4
630 UPPER RESPIRATORY TRACT INFLAMMATION 4
631 URINE KETONE BODY PRESENT 4
632 URINE OUTPUT DECREASED 4
633 VENTRICULAR FIBRILLATION 4
634 VISUAL IMPAIRMENT 4
635 ACUTE PULMONARY OEDEMA 3
636 ANAL ABSCESS 3
637 ANAL FISTULA 3
638 ANAPHYLACTIC REACTION 3
639 AORTIC DISSECTION 3
640 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3
641 BLOOD SODIUM DECREASED 3
642 BODY HEIGHT DECREASED 3
643 BONE DEMINERALISATION 3
644 BONE DISORDER 3
645 BRONCHIECTASIS 3
646 CANCER PAIN 3
647 CARDIOMEGALY 3
648 CAROTID ARTERY STENOSIS 3
649 CEREBRAL ARTERY EMBOLISM 3
650 CHRONIC HEPATITIS 3
651 CIRCULATORY COLLAPSE 3
652 CORONARY ARTERY BYPASS 3
653 CYTOMEGALOVIRUS VIRAEMIA 3
654 DERMATITIS 3
655 DERMATITIS BULLOUS 3
656 DISCOMFORT 3
657 DISTRIBUTIVE SHOCK 3
658 DIVERTICULUM INTESTINAL 3
659 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3
660 DRUG RESISTANCE 3
661 EMBOLISM 3
662 ESCHERICHIA SEPSIS 3
663 FEELING COLD 3
664 FEELING HOT 3
665 FIBRIN D DIMER INCREASED 3
666 FIBROMYALGIA 3
667 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3
668 FOOT FRACTURE 3
669 GALLBLADDER CANCER 3
670 GALLBLADDER DISORDER 3
671 GASTRIC DYSPLASIA 3
672 GINGIVAL OEDEMA 3
673 GINGIVAL PAIN 3
674 GLOSSODYNIA 3
675 GOUTY ARTHRITIS 3
676 GRAFT VERSUS HOST DISEASE 3
677 HAEMATOMA 3
678 HEPATIC CIRRHOSIS 3
679 HYDROCEPHALUS 3
680 HYPERBILIRUBINAEMIA 3
681 HYPERPARATHYROIDISM SECONDARY 3
682 HYPOALBUMINAEMIA 3
683 HYPOPHOSPHATAEMIA 3
684 HYPOVOLAEMIA 3
685 IATROGENIC INJURY 3
686 IDIOPATHIC PULMONARY FIBROSIS 3
687 ILEUS PARALYTIC 3
688 IMMOBILISATION SYNDROME 3
689 IMMUNE THROMBOCYTOPENIA 3
690 INFECTIOUS PLEURAL EFFUSION 3
691 INJECTION SITE BRUISING 3
692 INJECTION SITE MASS 3
693 INJECTION SITE PRURITUS 3
694 INJURY 3
695 INTERVERTEBRAL DISC PROTRUSION 3
696 JAUNDICE CHOLESTATIC 3
697 JOINT STIFFNESS 3
698 JOINT SWELLING 3
699 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 3
700 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3
701 LABORATORY TEST ABNORMAL 3
702 LACRIMATION INCREASED 3
703 LACTOSE INTOLERANCE 3
704 LEUKOCYTOSIS 3
705 LIP SWELLING 3
706 LIVER INJURY 3
707 LOCALISED INFECTION 3
708 LOWER GASTROINTESTINAL HAEMORRHAGE 3
709 LOWER RESPIRATORY TRACT INFECTION 3
710 LYMPHOCYTE MORPHOLOGY ABNORMAL 3
711 MACULAR FIBROSIS 3
712 MENINGITIS 3
713 MENTAL IMPAIRMENT 3
714 METASTASES TO CENTRAL NERVOUS SYSTEM 3
715 MOTOR DYSFUNCTION 3
716 MUSCLE FATIGUE 3
717 MUSCLE INJURY 3
718 MYOCARDITIS 3
719 NAIL DISORDER 3
720 NEPHROPATHY 3
721 NEPHROTIC SYNDROME 3
722 NERVOUS SYSTEM DISORDER 3
723 NERVOUSNESS 3
724 NEUROGENIC BLADDER 3
725 NEUROPSYCHOLOGICAL SYMPTOMS 3
726 NOCTURIA 3
727 NON-ALCOHOLIC STEATOHEPATITIS 3
728 NON-SMALL CELL LUNG CANCER 3
729 OBESITY 3
730 ORAL MUCOSA EROSION 3
731 ORTHOPNOEA 3
732 OSTEONECROSIS 3
733 PALLOR 3
734 PANCREATIC CARCINOMA METASTATIC 3
735 PANCREATITIS 3
736 PEMPHIGUS 3
737 PERIPHERAL ARTERY STENOSIS 3
738 PERIPHERAL COLDNESS 3
739 PERIPHERAL SENSORY NEUROPATHY 3
740 PLASMA CELL MYELOMA 3
741 PLEURISY 3
742 PNEUMONITIS 3
743 POST PROCEDURAL HAEMORRHAGE 3
744 POST PROCEDURAL INFECTION 3
745 PRODUCT AVAILABILITY ISSUE 3
746 PROTEIN TOTAL DECREASED 3
747 PSORIASIS 3
748 PSORIATIC ARTHROPATHY 3
749 RASH MACULAR 3
750 RECURRENCE OF NEUROMUSCULAR BLOCKADE 3
751 RED BLOOD CELL COUNT DECREASED 3
752 RENAL ABSCESS 3
753 RESPIRATORY ARREST 3
754 RETINAL ARTERY OCCLUSION 3
755 RHINOVIRUS INFECTION 3
756 SENSORY DISTURBANCE 3
757 SERUM FERRITIN INCREASED 3
758 SIALOADENITIS 3
759 SPRUE-LIKE ENTEROPATHY 3
760 STAPHYLOCOCCAL BACTERAEMIA 3
761 STAPHYLOCOCCAL INFECTION 3
762 STEROID DIABETES 3
763 SWELLING FACE 3
764 TASTE DISORDER 3
765 THALAMUS HAEMORRHAGE 3
766 THERAPEUTIC RESPONSE UNEXPECTED 3
767 THERAPY PARTIAL RESPONDER 3
768 THROMBOPHLEBITIS MIGRANS 3
769 TONGUE OEDEMA 3
770 TROPONIN T INCREASED 3
771 TUMOUR HAEMORRHAGE 3
772 TUMOUR LYSIS SYNDROME 3
773 TYPE 1 DIABETES MELLITUS 3
774 UNEVALUABLE EVENT 3
775 URETEROLITHIASIS 3
776 VASCULAR PSEUDOANEURYSM 3
777 VENTRICULAR HYPOKINESIA 3
778 ABNORMAL DREAMS 2
779 ABSCESS 2
780 ABSCESS JAW 2
781 ACNE 2
782 ACTINIC KERATOSIS 2
783 ADRENOCORTICAL INSUFFICIENCY ACUTE 2
784 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 2
785 ADVERSE DRUG REACTION 2
786 AGE-RELATED MACULAR DEGENERATION 2
787 AGEUSIA 2
788 AGITATION 2
789 AGRANULOCYTOSIS 2
790 ALCOHOL USE 2
791 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 2
792 ANGIOPLASTY 2
793 ANGULAR CHEILITIS 2
794 ANXIETY DISORDER 2
795 AORTIC VALVE INCOMPETENCE 2
796 AORTIC VALVE STENOSIS 2
797 APHTHOUS ULCER 2
798 APLASIA PURE RED CELL 2
799 APPLICATION SITE IRRITATION 2
800 APPLICATION SITE PAIN 2
801 ARTERIAL REVASCULARISATION 2
802 ARTERIAL STENOSIS 2
803 ARTERIOSPASM CORONARY 2
804 ARTHROPATHY 2
805 ASPHYXIA 2
806 ASPIRATION 2
807 ATELECTASIS 2
808 ATRIAL SEPTAL DEFECT 2
809 ATRIOVENTRICULAR BLOCK 2
810 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2
811 ATYPICAL FEMUR FRACTURE 2
812 AUTOIMMUNE PANCREATITIS 2
813 AUTONOMIC NEUROPATHY 2
814 BEHCET^S SYNDROME 2
815 BICYTOPENIA 2
816 BILE DUCT CANCER 2
817 BLADDER CANCER 2
818 BLISTER RUPTURE 2
819 BLOOD CHOLESTEROL DECREASED 2
820 BLOOD CREATININE DECREASED 2
821 BLOOD GLUCOSE ABNORMAL 2
822 BLOOD GLUCOSE DECREASED 2
823 BLOOD KETONE BODY INCREASED 2
824 BLOOD MAGNESIUM INCREASED 2
825 BLOOD SODIUM INCREASED 2
826 BLOOD THYROID STIMULATING HORMONE DECREASED 2
827 BLOOD THYROID STIMULATING HORMONE INCREASED 2
828 BLOOD URIC ACID INCREASED 2
829 BLOOD URINE PRESENT 2
830 BONE TUBERCULOSIS 2
831 BRONCHOPNEUMONIA 2
832 BRONCHOSPASM 2
833 CANCER SURGERY 2
834 CANDIDA INFECTION 2
835 CARCINOEMBRYONIC ANTIGEN INCREASED 2
836 CARCINOID TUMOUR 2
837 CARDIAC PACEMAKER INSERTION 2
838 CARDIOVASCULAR DISORDER 2
839 CD4 LYMPHOCYTES INCREASED 2
840 CELL DEATH 2
841 CELLULITIS ORBITAL 2
842 CEREBRAL ISCHAEMIA 2
843 CEREBRAL VASCULAR OCCLUSION 2
844 CERVIX CARCINOMA 2
845 CHOLANGIOCARCINOMA 2
846 CHOLECYSTECTOMY 2
847 CHOLERA 2
848 CHOLINERGIC SYNDROME 2
849 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2
850 CLAUSTROPHOBIA 2
851 CLOSTRIDIUM DIFFICILE INFECTION 2
852 COMBINED PULMONARY FIBROSIS AND EMPHYSEMA 2
853 COMPARTMENT SYNDROME 2
854 COMPLEX REGIONAL PAIN SYNDROME 2
855 CONGESTIVE HEPATOPATHY 2
856 CONJUNCTIVITIS BACTERIAL 2
857 CORONARY ARTERY DISSECTION 2
858 CORONARY ARTERY RESTENOSIS 2
859 CORONAVIRUS PNEUMONIA 2
860 CRANIOCEREBRAL INJURY 2
861 CROHN^S DISEASE 2
862 CUSHING^S SYNDROME 2
863 CUTANEOUS SYMPTOM 2
864 CYTOMEGALOVIRUS INFECTION REACTIVATION 2
865 DECREASED ACTIVITY 2
866 DEMENTIA ALZHEIMER^S TYPE 2
867 DERMATOMYOSITIS 2
868 DIABETIC FOOT 2
869 DIABETIC KETOSIS 2
870 DIABETIC RETINOPATHY 2
871 DIALYSIS 2
872 DISCOLOURED VOMIT 2
873 DISEASE RECURRENCE 2
874 DISORGANISED SPEECH 2
875 DISORIENTATION 2
876 DIZZINESS POSTURAL 2
877 DRUG EFFECT DECREASED 2
878 DRUG EFFECT LESS THAN EXPECTED 2
879 DRUG TITRATION ERROR 2
880 DRUG TOLERANCE 2
881 DRUG-DISEASE INTERACTION 2
882 DYSSTASIA 2
883 DYSTONIA 2
884 EATING DISORDER 2
885 ELECTROCARDIOGRAM ABNORMAL 2
886 EMBOLISM VENOUS 2
887 ENTERITIS INFECTIOUS 2
888 EOSINOPHIL COUNT INCREASED 2
889 EPIGASTRIC DISCOMFORT 2
890 ESCHERICHIA URINARY TRACT INFECTION 2
891 EXPOSURE VIA SKIN CONTACT 2
892 EYE DISORDER 2
893 EYE HAEMATOMA 2
894 EYE INFLAMMATION 2
895 EYE OEDEMA 2
896 EYE SWELLING 2
897 FEELING OF DESPAIR 2
898 FLANK PAIN 2
899 FLUID INTAKE REDUCED 2
900 FULL BLOOD COUNT ABNORMAL 2
901 FULL BLOOD COUNT DECREASED 2
902 FULMINANT TYPE 1 DIABETES MELLITUS 2
903 FUNCTIONAL GASTROINTESTINAL DISORDER 2
904 GASTRIC DILATATION 2
905 GASTRIC ULCER HAEMORRHAGE 2
906 GASTROENTERITIS VIRAL 2
907 GASTROINTESTINAL DYSPLASIA 2
908 GASTROINTESTINAL INFLAMMATION 2
909 GASTROINTESTINAL OEDEMA 2
910 GASTROINTESTINAL PAIN 2
911 GASTROINTESTINAL TOXICITY 2
912 GENERAL PHYSICAL CONDITION ABNORMAL 2
913 GENERALISED TONIC-CLONIC SEIZURE 2
914 GINGIVAL BLEEDING 2
915 GLAUCOMA 2
916 GLOMERULAR FILTRATION RATE ABNORMAL 2
917 GLUCOSE TOLERANCE IMPAIRED 2
918 GNATHOSCHISIS 2
919 GOITRE 2
920 GRANULOMATOSIS WITH POLYANGIITIS 2
921 HAEMODIALYSIS 2
922 HAEMORRHOIDS 2
923 HALLUCINATION, AUDITORY 2
924 HEAD INJURY 2
925 HEART FAILURE WITH REDUCED EJECTION FRACTION 2
926 HEART RATE IRREGULAR 2
927 HEAT EXHAUSTION 2
928 HELICOBACTER INFECTION 2
929 HEPATIC LESION 2
930 HEPATITIS C 2
931 HEPATITIS FULMINANT 2
932 HEPATITIS TOXIC 2
933 HEPATOCELLULAR CARCINOMA 2
934 HEPATOCELLULAR INJURY 2
935 HERNIA REPAIR 2
936 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 2
937 HODGKIN^S DISEASE 2
938 HYPERLACTACIDAEMIA 2
939 HYPERTENSIVE EMERGENCY 2
940 HYPERTONIC BLADDER 2
941 HYPERVENTILATION 2
942 HYPOGLYCAEMIC COMA 2
943 HYPOGLYCAEMIC UNCONSCIOUSNESS 2
944 HYPOPROTEINAEMIA 2
945 HYPOTHALAMO-PITUITARY DISORDER 2
946 HYPOVENTILATION 2
947 HYPOXIA 2
948 IGA NEPHROPATHY 2
949 IMMUNE-MEDIATED LUNG DISEASE 2
950 IMMUNE-MEDIATED THYROIDITIS 2
951 IMPAIRED DRIVING ABILITY 2
952 IMPAIRED GASTRIC EMPTYING 2
953 INABILITY TO AFFORD MEDICATION 2
954 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2
955 INCLUSION BODY MYOSITIS 2
956 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2
957 INCREASED APPETITE 2
958 INFLAMMATORY MARKER INCREASED 2
959 INGUINAL HERNIA 2
960 INJECTION SITE DISCOLOURATION 2
961 INJECTION SITE DISCOMFORT 2
962 INJECTION SITE RASH 2
963 INJECTION SITE URTICARIA 2
964 INSULIN C-PEPTIDE INCREASED 2
965 INTENTIONAL SELF-INJURY 2
966 IRON DEFICIENCY 2
967 IRON DEFICIENCY ANAEMIA 2
968 JOINT DEPOSIT 2
969 JOINT TUBERCULOSIS 2
970 KETOACIDOSIS 2
971 KIDNEY ENLARGEMENT 2
972 LABELLED DRUG-DRUG INTERACTION ISSUE 2
973 LARGE INTESTINAL HAEMORRHAGE 2
974 LIMB DISCOMFORT 2
975 LIP HAEMORRHAGE 2
976 LIP PAIN 2
977 LIPASE INCREASED 2
978 LIPID METABOLISM DISORDER 2
979 LISTLESS 2
980 LIVER ABSCESS 2
981 LUNG ADENOCARCINOMA STAGE II 2
982 MALIGNANT PERITONEAL NEOPLASM 2
983 MARASMUS 2
984 MECHANICAL ILEUS 2
985 MENTAL DISORDER 2
986 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 2
987 METASTASES TO LUNG 2
988 METASTASES TO LYMPH NODES 2
989 METASTASES TO MENINGES 2
990 MOOD ALTERED 2
991 MOUTH SWELLING 2
992 MULTIPLE SCLEROSIS RELAPSE 2
993 MUSCLE ABSCESS 2
994 MUSCLE STRAIN 2
995 MUSCULOSKELETAL CHEST PAIN 2
996 MYASTHENIA GRAVIS CRISIS 2
997 MYDRIASIS 2
998 MYOCARDIAL NECROSIS MARKER INCREASED 2
999 MYOCARDIAL RUPTURE 2